Pages that link to "Q46212846"

The following pages link to Blockade of potentiated startle responding in rats by 5-hydroxytryptamine1A receptor ligands (Q46212846):

Displaying 41 items.

• The GABA(B) receptor positive modulator BHF177 attenuated anxiety, but not conditioned fear, in rats (Q27305120) (← links)
• Altered exploration and sensorimotor gating of the chakragati mouse model of schizophrenia (Q30405594) (← links)
• The neurotensin-1 receptor agonist PD149163 blocks fear-potentiated startle (Q30427365) (← links)
• Delayed procedural learning in α7-nicotinic acetylcholine receptor knockout mice (Q30443234) (← links)
• Phasic and Sustained Fear are Pharmacologically Dissociable in Rats (Q30466236) (← links)
• Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety (Q30477934) (← links)
• Lesions of the habenula produce stress- and dopamine-dependent alterations in prepulse inhibition and locomotion (Q30493154) (← links)
• Role of corticotropin releasing factor in anxiety disorders: a translational research perspective (Q30498732) (← links)
• Amygdala and bed nucleus of the stria terminalis: differential roles in fear and anxiety measured with the acoustic startle reflex (Q30500018) (← links)
• 5-HT1B receptor knockout, but not 5-HT1A receptor knockout mice, show reduced startle reactivity and footshock-induced sensitization, as measured with the acoustic startle response (Q31870055) (← links)
• 5-HT2C ligands: recent progress (Q34766538) (← links)
• Buspirone and related compounds as alternative anxiolytics (Q36515213) (← links)
• Benzodiazepines, putative anxiolytics and animal models of anxiety (Q36649289) (← links)
• Animal Models of Anxiety and Anxiolytic Drug Action (Q37838926) (← links)
• 5-Hydroxytryptamine pathways in anxiety and its treatment (Q40457638) (← links)
• 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research (Q40465103) (← links)
• 5HT drugs in animal models of anxiety (Q40601511) (← links)
• Roles of the amygdala and bed nucleus of the stria terminalis in fear and anxiety measured with the acoustic startle reflex. Possible relevance to PTSD. (Q41544963) (← links)
• The involvement of 5-hydroxytryptaminergic and dopaminergic mechanisms in the eating induced by buspirone, gepirone and ipsapirone (Q42111096) (← links)
• Effects of buspirone, diazepam, and zolpidem on open field behavior, and brain [3H]muscimol binding after buspirone pretreatment. (Q42629966) (← links)
• Modulation of voltage-dependent calcium currents by serotonin in acutely isolated rat amygdala neurons (Q43700731) (← links)
• Tryptophan depletion alters the decision-making of healthy volunteers through altered processing of reward cues (Q44259246) (← links)
• GABA-A and 5-HT1A receptor agonists block expression of fear-potentiated startle in mice (Q44374768) (← links)
• Multiple serotonergic influences on startle responding (Q46066027) (← links)
• Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice (Q46075901) (← links)
• Effects of amygdaloid lesions, hippocampal lesions, and buspirone on black-white exploration and food carrying in rats (Q48347741) (← links)
• Serotonin depresses excitatory synaptic transmission and depolarization-evoked Ca2+ influx in rat basolateral amygdala via 5-HT1A receptors (Q48387281) (← links)
• Serotonin transporter gene variation impacts innate fear processing: Acoustic startle response and emotional startle. (Q48399008) (← links)
• The brain orexin system and almorexant in fear-conditioned startle reactions in the rat. (Q48509094) (← links)
• Double Dissociation between the Involvement of the Bed Nucleus of the Stria Terminalis and the Central Nucleus of the Amygdala in Startle Increases Produced by Conditioned versus Unconditioned Fear (Q48579580) (← links)
• Attenuation of chemically induced defence response by 5-HT1 receptor agonists administered into the periaqueductal gray (Q48586921) (← links)
• Changes in exploratory behaviour of hamsters following treatment with 8-hydroxy-2-(di-n-propylamino)tetralin (Q48915226) (← links)
• Fear-potentiated startle and light-enhanced startle models in drug discovery (Q50789854) (← links)
• Light-enhanced and fear-potentiated startle: temporal characteristics and effects of alpha-helical corticotropin-releasing hormone (Q51014424) (← links)
• Anxiogenic effects of high illumination levels assessed with the acoustic startle response in rats (Q51101232) (← links)
• Fear-potentiated startle response is remarkably similar in two laboratories (Q51112655) (← links)
• Predictive validity of the potentiated startle response as a behavioral model for anxiolytic drugs (Q51126115) (← links)
• Evidence for differential effects of 8-OH-DPAT on male and female rats in the Anxiety/Defense Test Battery (Q51154327) (← links)
• Sex-specific deficits in neurite density and white matter integrity are associated with targeted disruption of exon 2 of the Disc1 gene in the rat (Q61797149) (← links)
• Effect of serotoninergic drugs on stress-induced hyperthermia (SIH) in mice (Q68162835) (← links)
• Activation of somatodendritic 5-HT1A autoreceptors reduces the acquisition and expression of cued fear in the rat fear-potentiated startle test (Q90418873) (← links)